Clinical Trial Update: Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating activated marrow-infiltrating lymphocytes alone or with an allogeneic GM-CSF-based myeloma vaccine in autologous transplant for multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Activated marrow infiltrating lymphocytes (activated marrow infiltrating lymphocytes)
• GM-CSF-based myeloma cellular vaccine (allogeneic) (granulocyte macrophage colony-stimulating factor-based myeloma cellular vaccine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2019-10-08